Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R&S Northeast operates as a national pharmaceutical and medical supply wholesaler/distributor with a focus on serving 340B qualified entities, state/local governments, the Department of Defense, pharmacies, and universities. The company provides brand and generic pharmaceuticals—including controlled substances—and medical/surgical/infection control products. It does not conduct drug development or clinical trials but plays a key role in the healthcare supply chain. Recognized for outstanding customer service and support in the industry. Holds Verified‐Accredited Wholesale Distributor status from the National Association of Boards of Pharmacy. Preferred supplier to the 340B market through management of PHS, Apexus, AFAXYS pricing contracts; also manages GPO contracts with Premier, Innovatix, GeriMed, Armada, MedAssetts. Awarded AFAXYS GPO Services PACE Award for Outstanding Customer Service in 2014.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R&S Northeast.